Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brent Sabatini Insider Profile
4 Followers
Brent Sabatini, SVP, Chief Accounting Officer at Vir Biotechnology, holds 28.19K shares in Vir Biotechnology (Ticker: VIR). Most recently, Brent Sabatini Sold $1,562 shares of Vir Biotechnology on Feb 14, 2025 for an estimated value of 14.28K.
Brent Sabatini has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
SVP, Chief Accounting Officer
Roles that Brent Sabatini holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Brent Sabatini
Brent Sabatini's Trading History
List of latest transactions for each holding click on a transaction to see Brent Sabatini's performance on stock
You May Also Like
Brent Sabatini insider profile FAQ
What is the percentage of profitable transactions made by Brent Sabatini?
The percentage of profitable transactions made by Brent Sabatini is ―.
What is the average return per transaction made by Brent Sabatini?
The average return per transaction made by Brent Sabatini is ―.
What stocks does Brent Sabatini hold?
Brent Sabatini holds: VIR stocks.
What was Brent Sabatini’s latest transaction?
Brent Sabatini latest transaction was an Informative Sell of $14.28K.
What was Brent Sabatini's most profitable transaction?
Brent Sabatini’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Brent Sabatini's role in Vir Biotechnology?
Brent Sabatini's role in Vir Biotechnology is SVP, Chief Accounting Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.